Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Marker Therapeutics, Inc. in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NM
NEA Management Company, LLC
|
1.6M | 8.42% | Unchanged | ≤2021 | 0.2% | |
|
Shares held by quarter
Peak holding1.6M (Q4'24)
Change over 8 quarters+554.3K
Share of the company8.420%
|
||||||
|
BO
Blue Owl Capital Holdings LP
|
554.3K | 2.87% | Unchanged | 2024 | 0.1% | |
|
Shares held by quarter
Peak holding554.3K (Q4'24)
Change over 8 quarters+554.3K
Share of the company2.870%
|
||||||
27 more super investors behind a free account
See every manager holding Marker Therapeutics, Inc., how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$438K | 298.1K | 1.54% | 0.00% | June 30, 2026 |
|
VE
Vanguard Index Funds
|
$188K | 128.1K | 0.66% | 0.00% | June 30, 2026 |
4 more funds behind a free account
See every fund holding Marker Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NE
New Enterprise Associates 16, L.P.
5%+ holder
13D · 9.9%
|
1.7M | 8.65% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
NP
NEA Partners 16, L.P.
5%+ holder
13D · 9.9%
|
1.7M | 8.65% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Marker Therapeutics, Inc..
Sign up freeLoading...